Latest Prescription Drugs news
Obinutuzumab Efficacious for Renal Response in Lupus Nephritis
posted February 26th
by modernClinician Editorial Team
by modernClinician Editorial Team
One in Six Patients in Phase 2 Cancer Trials Receive Drug When Eventually Approved
posted February 26th
by modernClinician Editorial Team
by modernClinician Editorial Team
Acalabrutinib-Venetoclax Prolongs Survival in Previously Untreated Leukemia
posted February 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
Certain Glucose-Lowering Meds Associated With Lower Risk for COPD Exacerbations
posted February 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Air Pollution Does Not Impair Benefits of Walking in Reducing COPD Exacerbation Rate .jpg)
Pregnancy Complications Linked to Subsequent Risk for Cardiometabolic-Renal Conditions Related Articles
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria Monthly Specialist Briefings
Stay Connected
